Product Images Xifaxan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Xifaxan NDC 68258-1107 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NDC 68258-1107-XX - NDC 68258 1107 XX SALIX
This is a description of two different pharmaceutical products. The first, a pink-colored round biconvex tablet with the inscription "SX", dispensed by Salix Pharmaceuticals, Inc. with the product ID 65649-0301-03, is to be taken orally according to the doctor's prescription. The second is Xifaxan 200 mg tablets with product #1107-X containing Rifamixin. They are packaged exclusively by Dispensing Solutions in Santa Ana, CA 92704, and are available in XX tablets, bearing lot number "SAMPLE EXP:00-00" and RX# 33710186. The tablets must be kept out of children's reach, and the storage temperature should be between 68°-77°F.*
Kaplan-Meier Event-Free Curves_PivotalHEStudy - xifaxan 3
This is a statistical report on a clinical trial comparing the effectiveness of a placebo treatment. The hazard ratio of the placebo treatment is reported to be 0.5, indicating a lower risk of the event in the placebo group compared to the other treatment group. The trial involved 954 participants and the logrank p-value was reported to be 0.0129, suggesting a significant difference between the placebo and other treatment groups. However, the remaining text appears to be incomplete or unreadable, except for the label "Days Post-randomization".*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.